The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 15, 2014
Filed:
Apr. 20, 2009
Applicants:
Clive Allan Prestidge, Semaphore South, AU;
Spomenka Simovic, Adelaide, AU;
Inventors:
Clive Allan Prestidge, Semaphore South, AU;
Spomenka Simovic, Adelaide, AU;
Assignee:
University of South Australia, Adelaide, South Australia, AU;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 31/415 (2006.01); A61K 31/405 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 31/18 (2006.01); A61K 31/685 (2006.01); A61K 47/14 (2006.01); A61K 47/44 (2006.01); A61K 31/695 (2006.01);
U.S. Cl.
CPC ...
A61K 9/501 (2013.01); A61K 9/5089 (2013.01); A61K 9/5115 (2013.01); A61K 9/5192 (2013.01); A61K 31/405 (2013.01); A61K 31/18 (2013.01); A61K 31/685 (2013.01); A61K 47/14 (2013.01); A61K 47/44 (2013.01); A61K 31/695 (2013.01);
Abstract
A formulation for the delivery of an anti-inflammatory agent to a subject is described. In one particular application of the invention, the formulation comprises oil-based or aqueous droplets comprising indomethacin (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-H-indole-3-acetic acid) or celecoxib (4-[5-(4-methylphenyl)-3-(trifluoromethyl) pyrazol-1-yl]benzenesulfonamide) stabilized by nanoparticles, particularly silica nanoparticles.